Eli Lilly Earnings
NYSE: LLYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 29, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$9.83
Eli Lilly earnings summary
Eli Lilly is scheduled to report Sep/2026 earnings on Oct 29, 2026 before the market opens, with analysts expecting EPS of $9.83. In its most recent report on Aug 5, 2026 (Q2 2026), LLY posted EPS of $7.94. Revenue for the quarter was $22.97 billion.
Quarterly EPS is up 26.2% from the same quarter a year earlier. Across the last 16 reports, LLY shares moved an average of 4.3% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
LLY earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $7.94 | — | -0.5% |
| Apr 30, 2026 | — | $8.26 | — | -1.5% |
| Feb 12, 2026 | — | $7.39 | — | -2.9% |
| Oct 30, 2025 | — | $6.21 | — | +7.1% |
| Aug 7, 2025 | — | $6.29 | — | +12.1% |
| May 1, 2025 | — | $3.06 | — | -10.8% |
| Feb 19, 2025 | — | $4.88 | — | +5.4% |
| Oct 30, 2024 | — | $1.07 | — | +1.5% |
| Aug 8, 2024 | — | $3.28 | — | +3.4% |
| Apr 30, 2024 | — | $2.48 | — | +3.4% |
| Feb 21, 2024 | — | $2.42 | — | +1.6% |
| Nov 2, 2023 | — | $-0.06 | — | +5.3% |
| Aug 8, 2023 | — | $1.95 | — | +3.4% |
| Apr 27, 2023 | — | $1.49 | — | +8.1% |
| Feb 22, 2023 | — | $2.14 | — | -1.0% |
| Nov 1, 2022 | — | $1.61 | — | -1.4% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.